1095 related articles for article (PubMed ID: 33717193)
21. Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19.
Singh V; Obregon-Perko V; Lapp SA; Horner AM; Brooks A; Macoy L; Hussaini L; Lu A; Gibson T; Silvestri G; Grifoni A; Weiskopf D; Sette A; Anderson EJ; Rostad CA; Chahroudi A
JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35044955
[TBL] [Abstract][Full Text] [Related]
22. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.
Karthik K; Senthilkumar TMA; Udhayavel S; Raj GD
Hum Vaccin Immunother; 2020 Dec; 16(12):3055-3060. PubMed ID: 32845733
[TBL] [Abstract][Full Text] [Related]
23. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.
Ruetalo N; Businger R; Althaus K; Fink S; Ruoff F; Pogoda M; Iftner A; Ganzenmüller T; Hamprecht K; Flehmig B; Bakchoul T; Templin MF; Schindler M
mSphere; 2021 Feb; 6(1):. PubMed ID: 33627511
[TBL] [Abstract][Full Text] [Related]
24. Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome.
Caldarale F; Giacomelli M; Garrafa E; Tamassia N; Morreale A; Poli P; Timpano S; Baresi G; Zunica F; Cattalini M; Moratto D; Chiarini M; Cannizzo ES; Marchetti G; Cassatella MA; Taddio A; Tommasini A; Badolato R
Front Immunol; 2021; 12():654587. PubMed ID: 33841438
[TBL] [Abstract][Full Text] [Related]
25. Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding.
Peart Akindele N; Kouo T; Karaba AH; Gordon O; Fenstermacher KZJ; Beaudry J; Rubens JH; Atik CC; Zhou W; Ji H; Tao X; Vaidya D; Mostafa H; Caturegli P; Blair PW; Sauer L; Cox AL; Persaud D
J Infect Dis; 2021 Aug; 224(4):606-615. PubMed ID: 34398245
[TBL] [Abstract][Full Text] [Related]
26. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.
Ulrich H; Pillat MM; Tárnok A
Cytometry A; 2020 Jul; 97(7):662-667. PubMed ID: 32506725
[TBL] [Abstract][Full Text] [Related]
27. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.
Esteve-Sole A; Anton J; Pino-Ramirez RM; Sanchez-Manubens J; Fumadó V; Fortuny C; Rios-Barnes M; Sanchez-de-Toledo J; Girona-Alarcón M; Mosquera JM; Ricart S; Launes C; de Sevilla MF; Jou C; Muñoz-Almagro C; González-Roca E; Vergara A; Carrillo J; Juan M; Cuadras D; Noguera-Julian A; Jordan I; Alsina L
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497356
[TBL] [Abstract][Full Text] [Related]
28. Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in COVID-19 and Multisystem Inflammatory Syndrome in Children.
Avcu G; Arslan SY; Soylu M; Bilen NM; Bal ZS; Cicek C; Kurugol Z; Ozkinay F
Viral Immunol; 2022 Dec; 35(10):681-689. PubMed ID: 36534467
[TBL] [Abstract][Full Text] [Related]
29. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
Gruber CN; Patel RS; Trachtman R; Lepow L; Amanat F; Krammer F; Wilson KM; Onel K; Geanon D; Tuballes K; Patel M; Mouskas K; O'Donnell T; Merritt E; Simons NW; Barcessat V; Del Valle DM; Udondem S; Kang G; Gangadharan S; Ofori-Amanfo G; Laserson U; Rahman A; Kim-Schulze S; Charney AW; Gnjatic S; Gelb BD; Merad M; Bogunovic D
Cell; 2020 Nov; 183(4):982-995.e14. PubMed ID: 32991843
[TBL] [Abstract][Full Text] [Related]
30. Antibody-Dependent Enhancement of SARS-CoV-2 Infection of Human Immune Cells: In Vitro Assessment Provides Insight in COVID-19 Pathogenesis.
Shen XR; Li Q; Li HL; Wang X; Wang Q; Zheng XS; Geng R; Zhang YL; Li B; Jiang RD; Liu MQ; Zhu Y; Zhang W; Yang XL; Peng K; Zhou P
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960752
[TBL] [Abstract][Full Text] [Related]
31. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies.
Sánchez-Zuno GA; Matuz-Flores MG; González-Estevez G; Nicoletti F; Turrubiates-Hernández FJ; Mangano K; Muñoz-Valle JF
Int J Immunopathol Pharmacol; 2021; 35():20587384211050199. PubMed ID: 34632844
[TBL] [Abstract][Full Text] [Related]
32. Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19.
Matveev A; Pyankov O; Khlusevich Y; Tyazhelkova O; Emelyanova L; Timofeeva A; Shipovalov A; Chechushkov A; Zaitseva N; Kudrov G; Yusubalieva G; Yussubaliyeva S; Zhukova O; Baklaushev V; Sedykh S; Lifshits G; Tikunov A; Tikunova N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445984
[TBL] [Abstract][Full Text] [Related]
33. [The Challenges of Vaccine Development Against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector].
Zaichuk TA; Nechipurenko YD; Adzhubey AA; Onikienko SB; Chereshnev VA; Zainutdinov SS; Kochneva GV; Netesov SV; Matveeva OV
Mol Biol (Mosk); 2020; 54(6):922-938. PubMed ID: 33276356
[TBL] [Abstract][Full Text] [Related]
34. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
Bukulmez H
Curr Rheumatol Rep; 2021 Jul; 23(8):58. PubMed ID: 34216296
[TBL] [Abstract][Full Text] [Related]
35. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients.
Tornesello AL; Botti C; Micillo A; Labonia F; Arpino S; Isgrò MA; Meola S; Russo L; Cavalcanti E; Sale S; Nicastro C; Atripaldi L; Starita N; Cerasuolo A; Reimer U; Holenya P; Buonaguro L; Buonaguro FM; Tornesello ML
J Transl Med; 2023 Feb; 21(1):123. PubMed ID: 36788606
[TBL] [Abstract][Full Text] [Related]
36. Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19.
Boldova AE; Korobkin JD; Nechipurenko YD; Sveshnikova AN
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232664
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory and Autoimmune Aspects of Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Cohort Study.
Lawrence DA; Jadhav A; Mondal TK; Carson K; Lee WT; Hogan AH; Herbst KW; Michelow IC; Brimacombe M; Salazar JC; The Connecticut Children's Covid Collaborative
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932242
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry.
Matveeva O; Nechipurenko Y; Lagutkin D; Yegorov YE; Kzhyshkowska J
Front Immunol; 2022; 13():1050478. PubMed ID: 36532011
[TBL] [Abstract][Full Text] [Related]
39. Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS.
Fierz W; Walz B
Front Immunol; 2020; 11():1120. PubMed ID: 32582200
[TBL] [Abstract][Full Text] [Related]
40.
van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
